Patents by Inventor Mahmood Mirhoseini

Mahmood Mirhoseini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11801093
    Abstract: A system and method for transmyocardial laser revascularization (TMLR) in patients in need thereof, such as patients suffering from coronary artery disease. The system includes a Laser unit, an Electrocardiogram (EKG) unit, Vectorcardiography (VCG) unit, an Echocardiography unit, a spectrum Infrared sensor unit, and a control unit. The control unit can receive investigational data from different units and use the same to optimize the laser parameters. The Control unit can further include an AI module that can further analyze patient-related data, such as age and medical condition to further optimize the laser parameters. The laser unit can operate based on the optimized parameters to prevent unnecessary damage to the heart and allow maintaining the patency of the channels made by the laser for a longer duration.
    Type: Grant
    Filed: July 21, 2023
    Date of Patent: October 31, 2023
    Inventors: Mahmood Mirhoseini, Aria Manasheri
  • Patent number: 11331342
    Abstract: Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: May 17, 2022
    Inventors: Mahmood Mirhoseini, Aria Manasheri, Maryam Al Sadat Ahmadi, Siamak Nuhian
  • Publication number: 20210236762
    Abstract: Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.
    Type: Application
    Filed: March 29, 2021
    Publication date: August 5, 2021
    Inventors: Mahmood Mirhoseini, Aria Manasheri, Maryam Al Sadat Ahmadi, Siamak Nuhian
  • Patent number: 10376355
    Abstract: The embodiments herein relate to an artificial diaphragm made up of a plurality of plates having nanoparticles which move to-and-fro creating a movement similar to a natural diaphragm. The embodiments herein provide an artificial diaphragm that can mimic diaphragmatic movements of a natural diaphragm in a human body. The artificial diaphragm is embedded with intelligent nanomagnetic particles which is used for treatment of diaphragmatic paralysis.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: August 13, 2019
    Inventors: Tina Saber, Poona Saber, Mahmood Mirhoseini, Sassan Saber, Aria Manasheri
  • Publication number: 20180177584
    Abstract: The embodiments herein relate to an artificial diaphragm made up of a plurality of plates having nanoparticles which move to-and-fro creating a movement similar to a natural diaphragm. The embodiments herein provide an artificial diaphragm that can mimic diaphragmatic movements of a natural diaphragm in a human body. The artificial diaphragm is embedded with intelligent nanomagnetic particles which is used for treatment of diaphragmatic paralysis.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Inventors: Tina Saber, Poona Saber, Mahmood Mirhoseini, Sassan Saber, Aria Manasheri
  • Publication number: 20160025708
    Abstract: The embodiments herein disclose a non-invasive method of using bursts of energies/electromagnetic field energies from cells to reduce or arrest the growth rate, proliferation of cancer cells/neoplastic cells. The energy from cells induces apoptosis in cancer cells, without harming normal cells beyond their physiologic threshold of survival are provided. The embodiments herein disclose a method for treatment of cancer/neoplastic cell in human or animals within the context of cancer therapeutics. A cell culture plate is incubated. This plate serves as the source of bursts energies/electromagnetic field energies. Further with a device the bursts of energies are targeted to another plate having cells for one week. After one week the microscopic examination is done. The rate of growth of cell is six to seven pulsatile cells per square centimetre. The energy from cells kills cancer cells, induce apoptosis, stimulate growth phase in cell culture and enables harmonics therapy.
    Type: Application
    Filed: October 2, 2015
    Publication date: January 28, 2016
    Inventors: Mahmood Mirhoseini, Mary Cayton Mirhoseini, Aria Manasheri
  • Patent number: 9192703
    Abstract: The present invention is directed to a contractible and expandable jacket configured to encase at least a portion of a patient's heart. The jacket has a plurality of individual contractile cells with each of the cells having a first electrically conductive coil and a second electrically conductive coil spaced from the first coil. The first coil preferably defines at least in part a first periphery of an inner nucleus of the cell and the second coil preferably defining at least in part an outer portion of the cell spaced outwardly from the inner nucleus. When electrical current passes through the first and second coils in opposite directions, the cell contracts and when electrical current passes through the first and second coils in the same direction the cell expands. Each of the individual cells has conductive appendages for conducting information to and from the individual cells.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: November 24, 2015
    Inventors: Mahmood Mirhoseini, Mary Cayton Mirhoseini, Aria Manasheri
  • Publication number: 20150190562
    Abstract: The present invention is directed to a contractible and expandable jacket configured to encase at least a portion of a patient's heart. The jacket has a plurality of individual contractile cells with each of the cells having a first electrically conductive coil and a second electrically conductive coil spaced from the first coil. The first coil preferably defines at least in part a first periphery of an inner nucleus of the cell and the second coil preferably defining at least in part an outer portion of the cell spaced outwardly from the inner nucleus. When electrical current passes through the first and second coils in opposite directions, the cell contracts and when electrical current passes through the first and second coils in the same direction the cell expands. Each of the individual cells has conductive appendages for conducting information to and from the individual cells.
    Type: Application
    Filed: March 18, 2015
    Publication date: July 9, 2015
    Inventors: Mahmood Mirhoseini, Mary Cayton Mirhoseini, Aria Manasheri
  • Publication number: 20140249356
    Abstract: The present invention is directed to a contractible and expandable jacket configured to encase at least a portion of a patient's heart. The jacket has a plurality of individual contractile cells with each of the cells having a first electrically conductive coil and a second electrically conductive coil spaced from the first coil. The first coil preferably defines at least in part a first periphery of an inner nucleus of the cell and the second coil preferably defining at least in part an outer portion of the cell spaced outwardly from the inner nucleus. When electrical current passes through the first and second coils in opposite directions, the cell contracts and when electrical current passes through the first and second coils in the same direction the cell expands. Each of the individual cells has conductive appendages for conducting information to and from the individual cells.
    Type: Application
    Filed: September 24, 2011
    Publication date: September 4, 2014
    Inventors: Mahmood Mirhoseini, Mary Cayton Mirhoseini, Nosrat-o-liah Moktari, Aria Manasheri
  • Publication number: 20070185369
    Abstract: Cardiac assist device fully implantable within a patient and method of assisting the beating of the patient's heart. The cardiac assist device can include a cardiac jacket that wraps around at least a portion of the heart and a fluid reservoir coupled to the cardiac jacket. The cardiac assist device can include a pump that provides fluid to the cardiac jacket from the fluid reservoir and a motor coupled to the pump. A speed of the motor can control a fluid volume in the cardiac jacket. The cardiac assist device can include a pacemaker coupled to the motor. The pacemaker can control the speed of the motor based on cardiac parameters.
    Type: Application
    Filed: February 3, 2006
    Publication date: August 9, 2007
    Inventors: Mahmood Mirhoseini, Mary M. Cayton, Valerie Checkanov, Nosrart-o-llah Mokhtari, Ebrahim Afjei, Hossien Fajani, Mohammad Barandack
  • Patent number: 6869701
    Abstract: A protective coating for a substrate is disclosed having an outer component or module formed of a swellable material and an inner module formed of a plurality of layer or bilayers formed of ceramic material. The coating comprising a plurality of modules comprising a first module comprising a number (m) of bilayers comprising zirconia and alumina wherein (m) is a number greater than 1. The coating further comprises a second module disposed on the first module comprising a number (n) of bilayers comprising zirconia and titania wherein (n) is a number greater than 1. The coating further comprises a third module disposed on the second module comprising a third-module compound capable of forming a hydrate or hydroxide compound upon contact with an oxygen containing environment.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: March 22, 2005
    Inventors: Carolyn R. Aita, Vladislav V. Yakovlev, Mary M. Cayton, Mahmood Mirhoseini, Michael Aita
  • Patent number: 5925033
    Abstract: The method for intra-operative myocardial revascularization of a human heart includes a inserting a portion of an elongated flexible lasing apparatus into the chest cavity of a patient, and lasing channels from the epicardium through the myocardium of the heart, without mechanical tearing of the heart tissue. The apparatus is guided to an area exterior to a ventricle of the patient's heart, and the distal end of the optical fiber apparatus is directed to an area of interest where the exterior wall of the heart is irradiated with laser energy to form a channel through the myocardium.
    Type: Grant
    Filed: October 31, 1995
    Date of Patent: July 20, 1999
    Assignee: Cardiogenesis Corporation
    Inventors: Michael Aita, Mahmood Mirhoseini, Mary Cayton, Carl J. Simpson, Brian Guscott
  • Patent number: 5554152
    Abstract: The method for intra-operative myocardial revascularization of a human heart includes a inserting a portion of an elongated flexible lasing apparatus into the chest cavity of a patient, and lasing channels from the epicardium through the myocardium of the heart, without mechanical tearing of the heart tissue. The apparatus is guided to an area exterior to a ventricle of the patient's heart, and the distal end of the optical fiber apparatus is directed to an area of interest where the exterior wall of the heart is irradiated with laser energy to form a channel through the myocardium.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: September 10, 1996
    Assignee: CardioGenesis Corporation
    Inventors: Michael Aita, Mahmood Mirhoseini, Mary Cayton, Carl J. Simpson, Brian Guscott
  • Patent number: 5380316
    Abstract: The method for intra-operative myocardial revascularization of a human heart includes a inserting a portion of an elongated flexible lasing apparatus into the chest cavity of a patient, and lasing channels from the epicardium through the myocardium of the heart, without mechanical tearing of the heart tissue. The apparatus is guided to an area exterior to a ventricle of the patient's heart, and the distal end of the optical fiber apparatus is directed to an area of interest where the exterior wall of the heart is irradiated with laser energy to form a channel through the myocardium.
    Type: Grant
    Filed: June 16, 1993
    Date of Patent: January 10, 1995
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Michael Aita, Mahmood Mirhoseini, Mary Cayton, Carl J. Simpson, Brian Guscott